NCT03116932

Brief Summary

The target population for this project will be men-who-have-sex-with-men (MSM) at high risk of HIV acquisition

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
225

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2017

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 17, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

April 5, 2018

Status Verified

April 1, 2018

Enrollment Period

2.6 years

First QC Date

March 27, 2017

Last Update Submit

April 4, 2018

Conditions

Keywords

HIV prevention, high risk MSM, PrEP

Outcome Measures

Primary Outcomes (2)

  • PrEP acceptability using a PrEP knowledge and acceptability questionnaire.

    Measure the degree of acceptance of PrEP in the study subjects

    One visit

  • PrEP knowledge using a PrEP knowledge and acceptability questionnaire.

    Measure the level of education of the study subjects in the topic of PrEP using a questionnaire.

    One visit

Study Arms (1)

Part A - high risk MSM

Part A will consist of a descriptive analysis of the acceptability and knowledge on the topic of PrEP of the individuals that undergo routine HIV testing and counseling in study facilities or through outreach activities. Part A will be focused only on high risk MSM. For this part of the study, 225 high risk will be interviewed to understand the knowledge and acceptability of PrEP in this population in Puerto Rico.

Behavioral: PrEP knowledge and acceptability questionnaire

Interventions

This questionnaire consists of 187 items and evaluates socio-demographic variables, sex conducts, PrEP knowledge and PrEP acceptability.

Part A - high risk MSM

Eligibility Criteria

Age21 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale-to-female transgender subjects are eligible for enrollment
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

225 high risk men who have sex with men, HIV- subjects, 21 years or older , will be enrolled in Part A

You may qualify if:

  • age 21 years or older
  • understand and sign the informed consent form and willing to participate in the study
  • male or transgender female
  • has one of the following risk factors:
  • a high risk MSM as defined by:
  • having unprotected sexual intercourse with at least two male partners in the past 6 months, or
  • diagnosed with an STI in the past 6 months.

You may not qualify if:

  • Subjects with any of the following will not be considered for enrollment in Part A:
  • Age younger than 21 years old
  • Unable or unwilling to provide an informed consent
  • Female gender at birth
  • Do not meet the high risk criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Puerto Rico Community Network for Clinical Research on AIDS (PR-CoNCRA)

San Juan, PR, 00928, Puerto Rico

Location

Biospecimen

Retention: NONE RETAINED

Dried Blood Spots are obtained at 2 time points for participants in part B in order to assess adequate drug levels are retained for bulk shipping for processing at collaborating lab.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Vivian Tamayo-Agrait, MD

    787-753-9443

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 27, 2017

First Posted

April 17, 2017

Study Start

November 1, 2016

Primary Completion

June 1, 2019

Study Completion

November 1, 2019

Last Updated

April 5, 2018

Record last verified: 2018-04

Locations